Alpheus Medical Closes $16M In Series A Financing For Novel Glioma Brain Cancer Treatment
Funds to support first-in-human (FIH) clinical trial of the company's proprietary, non-invasive sonodynamic drug-device therapy system for recurrent high-grade gliomas.